|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
FY2020
12 months to Dec 31, 2020
|
FY2019
12 months to Dec 31, 2019
|
FY2018
12 months to Dec 31, 2018
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Test revenue | |||||
| Data/services | |||||
| Total revenue | |||||
| Operating expenses: | |||||
| Cost of revenue | |||||
| Research and development | |||||
| Selling and marketing | |||||
| General and administrative | |||||
| Goodwill and IPR&D impairment | |||||
| Restructuring and other costs | |||||
| Gain on sale of RUO kit assets | |||||
| Change in fair value of contingent consideration | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income (expense), net: | |||||
| Change in fair value of acquisition-related liabilities | |||||
| Other income, net | |||||
| Total other income (expense), net | |||||
| Interest expense | |||||
| Net loss before taxes | |||||
| Income tax benefit | |||||
| Net loss | |||||
| Net loss per share, basic (in dollars per share) | |||||
| Net loss per share, diluted (in dollars per share) | |||||
| Shares used in computing net loss per share, basic (in shares) | |||||
| Shares used in computing net loss per share, diluted (in shares) |
Loading...